The Journal of family practice
-
Clinical findings, as well as the patient's age and sex, pointed to the diagnosis.
-
We had our suspicions as to the diagnosis, but a particular sign was missing. The biopsy settled things.
-
This initiative increased patient acceptance of controlled substance agreements and random urine drug screening, and it led many patients to discontinue opioid therapy.
-
Here's what's known about the safety of these sweeteners and their effect on weight, appetite, and the risk for type 2 diabetes.
-
A systematic review and meta-analysis says, "Yes," but that doesn't necessarily mean they will start appearing on hospital formularies.